Soleus Capital Management’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2M Buy
585,958
+169,359
+41% +$2.51M 0.46% 51
2026
Q1
$6.04M Buy
+416,599
New +$5.16M 0.24% 60
2024
Q4
Sell
-201,903
Closed -$7.19M 88
2024
Q3
$7.19M Sell
201,903
-103,695
-34% -$3.57M 0.56% 47
2024
Q2
$9.35M Buy
+305,598
New +$8.73M 0.82% 40

Other funds holding BDSX

Soleus Capital Management's BDSX Position: Q2 2026 in Review

Soleus Capital Management increased its Biodesix (BDSX) stake by 41% in Q2 2026, buying an estimated $2.51M and bringing the position to 585,958 shares worth $13.2M. The position accounts for 0.46% of the portfolio, ranked #51.

Soleus Capital Management first reported a position in BDSX in Q2 2024 and has held it in 4 quarters since. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Soleus Capital Management held 585,958 shares of Biodesix worth $13.2M as of Q2 2026.
  • Soleus Capital Management bought 169,359 Biodesix shares in Q2 2026, an estimated $2.51M.
  • Biodesix made up 0.46% of Soleus Capital Management's portfolio in Q2 2026, its #51 holding.
  • Soleus Capital Management first reported a position in Biodesix in Q2 2024 and has held it in 4 quarters since.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.